Table 1—

Analysis of baseline metabolic status and the number of patients in predefined ranges

Laboratory characteristicLosartan (n = 751)Placebo (n = 762)
HbA1c (%)
 <7132 (17.6)138 (18.1)
 7–9375 (49.9)374 (49.1)
 9–12213 (28.4)224 (29.4)
 >1222 (2.9)18 (2.4)
Total cholesterol (mg/dl)
 <200253 (33.7)248 (32.5)
 200–240242 (32.2)236 (31.0)
 >240248 (33.0)271 (35.6)
HDL cholesterol (mg/dl)
 <40337 (44.9)345 (45.3)
 40–60298 (39.7)312 (40.9)
 >60104 (13.8)95 (12.5)
LDL cholesterol (mg/dl)
 <130301 (40.1)297 (39.0)
 130–160186 (24.8)175 (23.0)
 160–190104 (13.8)116 (15.2)
 >19085 (11.3)95 (12.5)
Triglycerides (mg/dl)
 <200476 (63.4)460 (60.4)
 200–500230 (30.6)254 (33.3)
 >50037 (4.9)41 (5.4)
  • Data are n (%). Ranges predefined by American Diabetes Association (8) and Adult Treatment Panel III (9) guidelines.